- Report
- November 2023
- 101 Pages
Asia Pacific
From €1165EUR$1,225USD£978GBP
€2329EUR$2,450USD£1,957GBP
- Report
- January 2024
- 135 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- October 2023
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- April 2023
- 115 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- March 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- March 2023
- 211 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- August 2023
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- October 2019
- 163 Pages
Europe
From €3280EUR$3,450USD£2,755GBP
- Report
- January 2024
- 159 Pages
Global
€4749EUR$4,995USD£3,989GBP
- Report
- February 2024
- 93 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- June 2023
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- July 2021
- 243 Pages
Global
From €3529EUR$3,712USD£2,965GBP

The Oligonucleotide Synthesis market is a segment of the biotechnology industry that focuses on the production of short, single-stranded DNA or RNA molecules. These molecules are used in a variety of applications, such as gene therapy, drug discovery, and diagnostics. Oligonucleotides are synthesized using a variety of techniques, including phosphoramidite chemistry, phosphorothioate chemistry, and solid-phase synthesis.
The Oligonucleotide Synthesis market is driven by the increasing demand for gene therapy and personalized medicine. Additionally, the development of new technologies, such as next-generation sequencing, has enabled the production of more complex oligonucleotides.
Some of the major players in the Oligonucleotide Synthesis market include Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, Eurofins Scientific, and Bio-Synthesis. Show Less Read more